HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bernard T Golding Selected Research

3- (4- chlorophenyl)- 3- (4- hydroxy- 3,5- dimethoxybenzyloxy)- 2- propyl- 2,3- dihydroisoindol- 1- one

10/2006Small-molecule inhibitors of the MDM2-p53 protein-protein interaction based on an isoindolinone scaffold.
3/2005Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interaction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bernard T Golding Research Topics

Disease

18Neoplasms (Cancer)
12/2022 - 10/2002
5Dehydration (Water Stress)
01/2008 - 03/2004
2Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 05/2004
2Carcinogenesis
07/2011 - 07/2004
2Sarcoma (Soft Tissue Sarcoma)
10/2006 - 03/2005
1Osteosarcoma (Osteogenic Sarcoma)
01/2021
1Melanoma (Melanoma, Malignant)
01/2016
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
01/2016
1Prostatic Neoplasms (Prostate Cancer)
01/2012
1Ataxia Telangiectasia (Louis Bar Syndrome)
04/2007
1Carcinoma (Carcinomatosis)
09/2005
1Ovarian Neoplasms (Ovarian Cancer)
09/2005

Drug/Important Bio-Agent (IBA)

6Phosphotransferases (Kinase)IBA
12/2022 - 04/2007
4EnzymesIBA
01/2021 - 01/2012
3crotonyl-coenzyme A (crotonyl-CoA)IBA
01/2008 - 02/2005
2Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2012
2Pharmaceutical PreparationsIBA
01/2016 - 01/2016
2Caspase 3 (Caspase-3)IBA
01/2012 - 09/2005
2Caspase 9IBA
01/2012 - 09/2005
2CarcinogensIBA
07/2011 - 09/2009
2DNA AdductsIBA
07/2011 - 07/2004
23- (4- chlorophenyl)- 3- (4- hydroxy- 3,5- dimethoxybenzyloxy)- 2- propyl- 2,3- dihydroisoindol- 1- oneIBA
10/2006 - 03/2005
24-hydroxybutyryl-coenzyme AIBA
10/2005 - 02/2005
1Mitogen-Activated Protein KinasesIBA
12/2022
1LigandsIBA
01/2021
1Protein Kinases (Protein Kinase)IBA
06/2020
1Adenosine Triphosphatases (ATPase)IBA
01/2018
1MTOR InhibitorsIBA
01/2016
1Antimalarials (Antimalarial Agents)IBA
01/2016
1Antineoplastic Agents (Antineoplastics)IBA
01/2016
1Pyrimethamine (Daraprim)FDA Link
01/2016
1methylbenzoprimIBA
01/2016
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2016
1TOR Serine-Threonine KinasesIBA
01/2016
1Cysteine (L-Cysteine)FDA Link
01/2014
1Histones (Histone)IBA
01/2012
11,2-bis(isothiazol-5-yl)disulfaneIBA
01/2012
1Androgen Receptors (Androgen Receptor)IBA
01/2012
1Lysine (L-Lysine)FDA Link
01/2012
1ProdrugsIBA
09/2011
1Cyclin-Dependent Kinase 2IBA
09/2011
1NU6102IBA
09/2011
1isopreneIBA
07/2011
1Codon (Codons)IBA
07/2011
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
05/2010
11,3-butadiene (divinyl)IBA
09/2009
1ThymidineIBA
07/2009
1NU 3153IBA
07/2009
1Folic Acid AntagonistsIBA
07/2009
1Pemetrexed (MTA)FDA Link
07/2009
1Coenzyme A (CoA)IBA
01/2008
1DNA-Activated Protein KinaseIBA
04/2007
12- benzyl- 3- (4- chlorophenyl)- 3- (3- hydroxypropoxy)- 2,3- dihydroisoindol- 1- oneIBA
10/2006
1AnionsIBA
10/2005
1Paclitaxel (Taxol)FDA LinkGeneric
09/2005
14- (6- cyclohexylmethoxy- 9H- purin- 2- ylamino)- N,N- diethylbenzamideIBA
09/2005
16- ((3- chloro)anilino)- 2- (isopropyl- 2- hydroxyethylamino)- 9- isopropylpurineIBA
09/2005
1SurvivinIBA
09/2005
1benzene oxideIBA
02/2005
1Glutathione (Reduced Glutathione)IBA
02/2005
1Oxepins (Oxepin)IBA
02/2005
1Benzene (Benzole)IBA
02/2005
1Acetylcysteine (Siran)FDA LinkGeneric
02/2005
14-hydroxybutyryl-CoA dehydrataseIBA
02/2005
1S-phenyl-N-acetylcysteineIBA
02/2005
1Biomarkers (Surrogate Marker)IBA
07/2004
1DNA (Deoxyribonucleic Acid)IBA
05/2004
1Temozolomide (Temodar)FDA LinkGeneric
05/2004
1IminesIBA
03/2004
11,4-dihydropyridine (dihydropyridine)IBA
03/2004
1Hydroxyl RadicalIBA
03/2004
1Cytotoxins (Cytolysins)IBA
11/2002
1Cyclin-Dependent Kinases (cdk Proteins)IBA
10/2002

Therapy/Procedure

3Therapeutics
03/2017 - 09/2005
1Oral Administration
01/2021
1Heterologous Transplantation (Xenotransplantation)
01/2016